Erich Minar

Q: What Schools Are Affiliated With Erich Minar

Erich Minar is affiliated with the following schools: Medical University of Vienna, University of Vienna

Erich Minar's AcademicInfluence.com Rankings

Erich Minar

Philosophy

#9384

World Rank

#12937

Historical Rank

Logic

#6364

World Rank

#7876

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Erich Minar's Degrees

Doctorate Medicine University of California, San Francisco

Why Is Erich Minar Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Erich Minar's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Oral rivaroxaban for the treatment of symptomatic pulmonary embolism. (2012) (1713)
ESC Guidelines on the Diagnosis and Treatment of Peripheral Artery Diseases (2012) (1546)
Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. (2006) (1117)
High plasma levels of factor VIII and the risk of recurrent venous thromboembolism. (2000) (606)
Nitinol Stent Implantation Versus Percutaneous Transluminal Angioplasty in Superficial Femoral Artery Lesions up to 10 cm in Length: The Femoral Artery Stenting Trial (FAST) (2007) (502)
Sustained Benefit at 2 Years of Primary Femoropopliteal Stenting Compared With Balloon Angioplasty With Optional Stenting (2007) (488)
The risk of recurrent venous thromboembolism in men and women. (2004) (480)
Impact of Weight Loss on Inflammatory Proteins and Their Association With the Insulin Resistance Syndrome in Morbidly Obese Patients (2003) (417)
The role of heme oxygenase-1 promoter polymorphisms in human disease. (2004) (390)
Simvastatin Reduces Expression of Cytokines Interleukin-6, Interleukin-8, and Monocyte Chemoattractant Protein-1 in Circulating Monocytes From Hypercholesterolemic Patients (2002) (386)
D-dimer levels and risk of recurrent venous thromboembolism. (2003) (337)
Overweight, obesity, and the risk of recurrent venous thromboembolism. (2008) (291)
Results of the randomized, placebo-controlled clopidogrel and acetylsalicylic acid in bypass surgery for peripheral arterial disease (CASPAR) trial. (2010) (280)
The post‐thrombotic syndrome: risk factors and impact on the course of thrombotic disease (2005) (271)
Endurance training increases the number of endothelial progenitor cells in patients with cardiovascular risk and coronary artery disease. (2005) (267)
Balloon angioplasty versus stenting with nitinol stents in intermediate length superficial femoral artery lesions (2009) (252)
Long-Segment SFA Stenting—The Dark Sides: In-Stent Restenosis, Clinical Deterioration, and Stent Fractures (2005) (244)
Incidence of pseudoaneurysm after diagnostic and therapeutic angiography. (1995) (234)
The Risk of Recurrent Venous Thromboembolism in Patients with and without Factor V Leiden (1997) (219)
Endovascular Brachytherapy for Prophylaxis of Restenosis After Femoropopliteal Angioplasty: Results of a Prospective Randomized Study (2000) (205)
Clinical in vitro endothelialization of femoropopliteal bypass grafts: an actuarial follow-up over three years. (1994) (204)
Primary patency of femoropopliteal arteries treated with nitinol versus stainless steel self-expanding stents: propensity score-adjusted analysis. (2004) (190)
Inflammation and Carotid Artery—Risk for Atherosclerosis Study (ICARAS) (2005) (176)
Heme Oxygenase-1 Gene Promoter Microsatellite Polymorphism is Associated with Restenosis after Percutaneous Transluminal Angioplasty (2001) (172)
Simvastatin Blunts Endotoxin-Induced Tissue Factor In Vivo (2005) (164)
Endothelial cell seeding of polytetrafluoroethylene vascular grafts in humans: a preliminary report. (1987) (163)
Thrombin-activatable fibrinolysis inhibitor and the risk for recurrent venous thromboembolism. (2004) (162)
Simvastatin Reduces the Expression of Adhesion Molecules in Circulating Monocytes From Hypercholesterolemic Patients (2003) (152)
Primary Patency of Long-Segment Self-Expanding Nitinol Stents in the Femoropopliteal Arteries (2005) (151)
Post-thrombotic syndrome after primary event of deep venous thrombosis 10 to 20 years ago. (2001) (150)
The Risk of Early Recurrent Venous Thromboembolism after Oral Anticoagulant Therapy in Patients with the G20210A Transition in the Prothrombin Gene (1999) (146)
Does Carotid Stent Cell Design Matter? (2008) (145)
Carotid Artery Stenting: Effect of Learning Curve and Intermediate-Term Morphological Outcome (2001) (140)
A call for uniform reporting standards in studies assessing endovascular treatment for chronic ischaemia of lower limb arteries. (2007) (140)
PTA Versus Carbofilm-Coated Stents in Infrapopliteal Arteries: Pilot Study (2006) (133)
Osteoprotegerin plasma concentrations correlate with severity of peripheral artery disease. (2005) (131)
Hypotension and Bradycardia after Elective Carotid Stenting: Frequency and Risk Factors (2003) (129)
Complement component C5a predicts future cardiovascular events in patients with advanced atherosclerosis. (2005) (128)
Quantification of internal carotid artery stenosis with duplex US: comparative analysis of different flow velocity criteria. (2004) (128)
Symptomatic pulmonary embolism and the risk of recurrent venous thromboembolism. (2004) (127)
Conventional balloon angioplasty versus peripheral cutting balloon angioplasty for treatment of femoropopliteal artery in-stent restenosis: initial experience. (2008) (124)
One-Year Outcome of Percutaneous Rotational Atherectomy with Aspiration in Infrainguinal Peripheral Arterial Occlusive Disease: The Multicenter Pathway PVD Trial (2009) (124)
Deep venous thrombosis of the lower extremity: efficacy of spiral CT venography compared with conventional venography in diagnosis. (1996) (122)
Vascular inflammation and percutaneous transluminal angioplasty of the femoropopliteal artery: association with restenosis. (2002) (120)
Statin therapy improves cardiovascular outcome of patients with peripheral artery disease. (2004) (110)
Heme oxygenase-1 gene promoter polymorphism is associated with abdominal aortic aneurysm. (2002) (109)
Asymmetric Dimethylarginine Predicts Major Adverse Cardiovascular Events in Patients With Advanced Peripheral Artery Disease (2006) (107)
Joint Effects of C-Reactive Protein and Glycated Hemoglobin in Predicting Future Cardiovascular Events of Patients With Advanced Atherosclerosis (2003) (107)
Progression of Carotid Stenosis Detected by Duplex Ultrasonography Predicts Adverse Outcomes in Cardiovascular High-Risk Patients (2007) (107)
Weight loss reduces tissue factor in morbidly obese patients. (2003) (102)
Association of neutrophils and future cardiovascular events in patients with peripheral artery disease. (2005) (101)
Heme oxygenase-1 genotype and restenosis after balloon angioplasty: a novel vascular protective factor. (2004) (101)
The risk of recurrent venous thromboembolism among patients with high factor IX levels (2003) (101)
Comparison of effects of high-dose and low-dose aspirin on restenosis after femoropopliteal percutaneous transluminal angioplasty. (1995) (99)
D-Dimer and TAT Measurement in Patients with Deep Venous Thrombosis: Utility in Diagnosis and Judgement of Anticoagulant Treatment Effectiveness (1990) (99)
Value of color duplex sonography for evaluation of tibioperoneal arteries in patients with femoropopliteal obstruction: a prospective comparison with anterograde intraarterial digital subtraction angiography. (1997) (96)
Association of a Functional Polymorphism in the Clopidogrel Target Receptor Gene, P2Y12, and the Risk for Ischemic Cerebrovascular Events in Patients With Peripheral Artery Disease (2005) (94)
Risk Stratification for Subclavian Artery Angioplasty: Is There an Increased Rate of Restenosis after Stent Implantation? (2001) (89)
Treatment of subclavian-axillary vein thrombosis: long-term outcome of anticoagulation versus systemic thrombolysis. (2002) (87)
Restenosis After Percutaneous Angioplasty: The Role of Vascular Inflammation (2005) (86)
Acute-phase response after stent implantation in the carotid artery: association with 6-month in-stent restenosis. (2003) (85)
Prospective clinical study with in vitro endothelial cell lining of expanded polytetrafluoroethylene grafts in crural repeat reconstruction. (1992) (84)
Dental and Periodontal Status and Risk for Progression of Carotid Atherosclerosis: The Inflammation and Carotid Artery Risk for Atherosclerosis Study Dental Substudy (2006) (84)
The risk of recurrent venous thromboembolism in heterozygous carriers of factor V Leiden and a first spontaneous venous thromboembolism. (2002) (83)
Brachytherapy for prophylaxis of restenosis after long-segment femoropopliteal angioplasty: pilot study. (1998) (82)
Penetration of Ciprofloxacin into the Interstitial Space of Inflamed Foot Lesions in Non-Insulin-Dependent Diabetes Mellitus Patients (1999) (80)
Restenosis after Percutaneous Transluminal Angioplasty in the Femoropopliteal Segment: The Role of Inflammation (2001) (79)
Low Serum Magnesium Predicts Neurological Events in Patients With Advanced Atherosclerosis (2003) (75)
Inflammatory response to stent implantation: differences in femoropopliteal, iliac, and carotid arteries. (2002) (74)
Prognostic Impact of Fibrinogen in Carotid Atherosclerosis: Nonspecific Indicator of Inflammation or Independent Predictor of Disease Progression? (2005) (73)
Superficial thrombophlebitis and risk for recurrent venous thromboembolism. (2003) (72)
Monitoring of antiplatelet therapy with the PFA-100® in peripheral angioplasty patients (2002) (72)
Angiotensin Receptor Blockade Decreases Markers of Vascular Inflammation (2004) (72)
INFLUENCE OF POSTOPERATIVE ANTICOAGULANT TREATMENT ON PATIENT SURVIVAL AFTER FEMOROPOPLITEAL VEIN BYPASS SURGERY (1988) (69)
Single-Center Experience with Carotid Stent Restenosis (2002) (69)
Percutaneous Treatment of Peripheral Artery Disease: Novel Techniques (2012) (68)
Myeloperoxidase predicts progression of carotid stenosis in states of low high-density lipoprotein cholesterol. (2006) (67)
Edoxaban Plus Aspirin vs Dual Antiplatelet Therapy in Endovascular Treatment of Patients With Peripheral Artery Disease: Results of the ePAD Trial (2018) (67)
Tissue factor pathway inhibitor and the risk of recurrent venous thromboembolism (2005) (66)
In vitro and in vivo evaluation of [18F]ciprofloxacin for the imaging of bacterial infections with PET (2005) (66)
Platelets in hyperthyroidism: studies on platelet counts, mean platelet volume, 111-indium-labeled platelet kinetics, and platelet-associated immunoglobulins G and M. (1990) (65)
Femoropopliteal arteries: immediate and long-term results with a Dacron-covered stent-graft. (2002) (65)
Functional asplenia after bone marrow transplantation. A late complication related to extensive chronic graft-versus-host disease. (1988) (61)
Penetration of Moxifloxacin into Healthy and Inflamed Subcutaneous Adipose Tissues in Humans (2003) (61)
Family history for venous thromboembolism and the risk for recurrence. (2006) (61)
Increasing carotid plaque echolucency is predictive of cardiovascular events in high-risk patients. (2008) (61)
Endovascular revascularization below the knee: 6-month results and predictive value of C-reactive protein level. (2003) (61)
Intraarterial (192)Ir high-dose-rate brachytherapy for prophylaxis of restenosis after femoropopliteal percutaneous transluminal angioplasty: the prospective randomized Vienna-2-trial radiotherapy parameters and risk factors analysis. (2000) (60)
Endovascular AAA treatment: expensive prestige or economic alternative? (1997) (59)
C‐reactive protein in the diagnosis of deep vein thrombosis (2002) (59)
Beta 2 Microglobulin and the Risk for Cardiovascular Events in Patients With Asymptomatic Carotid Atherosclerosis (2011) (59)
The long‐term recurrence risk of patients with unprovoked venous thromboembolism: an observational cohort study (2016) (58)
Duplex Sonography versus Angiography for Assessment of Femoropopliteal Arterial Disease in a “Real-World” Setting (2007) (57)
C-Reactive Protein Predicts Future Cardiovascular Events in Patients With Carotid Stenosis (2007) (55)
Superficial vein thrombosis: a consensus statement. (2012) (54)
The influence of anticoagulant treatment on the probability of function in femoropopliteal vein bypass surgery: analysis of a clinical series (1970 to 1985) and interim evaluation of a controlled clinical trial. (1987) (54)
Effect of lovastatin on hemorheology in type II hyperlipoproteinemia. (1990) (54)
Effect of Glycoprotein IIb/IIIa Antagonist Abciximab on Monocyte-Platelet Aggregates and Tissue Factor Expression (2003) (52)
Haem oxygenase‐1 genotype and cardiovascular adverse events in patients with peripheral artery disease (2005) (52)
Activation of coagulation and fibrinolysis in patients with arteriosclerosis: relation to localization of vessel disease and risk factors. (1990) (51)
Inhibition of restenosis by tissue factor pathway inhibitor: in vivo and in vitro evidence for suppressed monocyte chemoattraction and reduced gelatinolytic activity. (2004) (51)
Arterial Puncture Site Management after Percutaneous Transluminal Procedures Using a Hemostatic Wound Dressing (Clo-Sur P.A.D.) versus Conventional Manual Compression: A Randomized Controlled Trial (2006) (51)
Endovascular brachytherapy for prophylaxis against restenosis after long-segment femoropopliteal placement of stents: initial results. (2001) (49)
Implantation of in vitro endothelialized polytetrafluoroethylene grafts in human beings. A preliminary report. (1992) (48)
Past, Present and Future of Femoropopliteal Stenting (2009) (48)
Prediction of iatrogenic pseudoaneurysm after percutaneous endovascular procedures. (2006) (47)
Neuropsychological Outcome 6 Months after Unilateral Carotid Stenting (2005) (46)
Balloon angioplasty and stent implantation induce a vascular inflammatory reaction. (2002) (45)
Symptomatic pulmonary embolism and the risk of recurrent venous thromboembolism (2004) (45)
Outcome of Conservative versus Interventional Treatment of Subclavian Artery Stenosis (2002) (45)
Endovascular brachytherapy prevents restenosis after femoropopliteal angioplasty: results of the Vienna-3 randomised multicenter study. (2005) (44)
Tissue pharmacokinetics of levofloxacin in human soft tissue infections. (2004) (44)
Heme Oxygenase-1 Genotype is a Vascular Anti-inflammatory Factor following Balloon Angioplasty (2002) (44)
Covered versus Bare Self-Expanding Stents for Endovascular Treatment of Carotid Artery Stenosis: A Stopped Randomized Trial (2006) (44)
De novo superficial femoropopliteal artery lesions: peripheral cutting balloon angioplasty and restenosis rates--randomized controlled trial. (2008) (44)
Contralateral high-grade carotid artery stenosis or occlusion is not associated with increased risk for poor neurologic outcome after elective carotid stent placement. (2004) (44)
Abciximab Reduces Monocyte Tissue Factor in Carotid Angioplasty and Stenting (2003) (43)
Critical limb ischaemia. (2009) (43)
Plaque Echolucency Is Not Associated With the Risk of Stroke in Carotid Stenting (2006) (42)
Elevated lipoprotein(a) and increased incidence of restenosis after femoropopliteal PTA. Rationale for the higher risk of recurrence in females? (1996) (42)
Basal high-sensitivity-C-reactive protein levels in patients with spontaneous venous thromboembolism (2005) (42)
Angioplasty increases target site concentrations of ciprofloxacin in patients with peripheral arterial occlusive disease (2001) (41)
Predictors of Long-Term Results After Treatment of Iliac Artery Obliteration by Transluminal Angioplasty and Stent Deployment (2002) (41)
Influence of anticoagulant treatment in preventing graft occlusion following saphenous vein bypass for femoropopliteal occlusive disease (1986) (41)
Fibrinogen predicts mortality in high risk patients with peripheral artery disease. (2003) (40)
Platelet deposition at angioplasty sites and its relation to restenosis in human iliac and femoropopliteal arteries. (1989) (39)
B-flow evaluation of carotid arterial stenosis: initial experience. (2002) (38)
Serum albumin predicts cardiac adverse events in patients with advanced atherosclerosis – interrelation with traditional cardiovascular risk factors (2004) (38)
Serum creatinine predicts mortality in patients with peripheral artery disease: influence of diabetes and hypertension. (2004) (38)
Effect of smoking on restenosis during the 1st year after lower-limb endovascular interventions. (2004) (38)
Long‐term outcome of primary Raynaud's phenomenon and its conversion to connective tissue disease: a 12‐year retrospective patient analysis (2003) (38)
Value of negative spiral CT angiography in patients with suspected acute PE: analysis of PE occurrence and outcome (2004) (37)
Multicentre evaluation of a new point-of-care test for the quantitative determination of D-dimer. (2001) (37)
Homocyst(e)ine-lowering therapy does not affect plasma asymmetrical dimethylarginine concentrations in patients with peripheral artery disease. (2005) (37)
Plaque imaging of the internal carotid artery - correlation of B-flow imaging with histopathology. (2007) (36)
Lipoprotein (a) in patients with aortic aneurysmal disease. (2002) (36)
Procedure-Related Complications and Early Neurological Adverse Events of Unprotected and Protected Carotid Stenting: Temporal Trends in a Consecutive Patient Series (2005) (35)
The first 15 months of transluminal abdominal aortic aneurysm management: a single centre experience. (1997) (35)
Complications after Peripheral Vascular Interventions in Octogenarians (2008) (35)
Successful revascularization of acute carotid stent thrombosis by facilitated thrombolysis. (2004) (35)
Renal artery stenosis predicts adverse cardiovascular and renal outcome in patients with peripheral artery disease (2009) (34)
Carotid Artery Stenting in Older Patients: Is Age a Risk Factor for Poor Outcome? (2002) (34)
E-Selectin and restenosis after femoropopliteal angioplasty: prognostic impact of the Ser128Arg genotype and plasma levels (2003) (33)
Results of a new rapid d-dimer assay (cardiac d-dimer) in the diagnosis of deep vein thrombosis. (2001) (33)
Indium-111-labeled platelet scintigraphy in carotid atherosclerosis. (1989) (33)
Assessment of self-expanding nitinol stent deformation after chronic implantation into the femoropopliteal arteries. (2013) (33)
Endothelial Progenitor Cells in Kidney Transplant Recipients (2006) (32)
Deep vein thrombosis: scintigraphic diagnosis with In-111-labeled monoclonal antifibrin antibodies. (1989) (32)
AMS INSIGHT—Absorbable Metal Stent Implantation for Treatment of Below-the-Knee Critical Limb Ischemia: 6-Month Analysis (2009) (32)
Neointimal proliferation within carotid stents is more pronounced in diabetic patients with initial poor glycaemic state (2004) (31)
Interleukin-6 and interleukin-6 promoter polymorphism (−174) G>C in patients with spontaneous venous thromboembolism (2006) (31)
Balloon Angioplasty and Stent Implantation Induce a Vascular Inflammatory Reaction (2002) (31)
Ultrasound guided compression therapy in 134 patients with iatrogenic pseudo-aneurysms: advantage of routine duplex ultrasound control of the puncture site following transfemoral catheterization. (1997) (31)
Gender differences in outcome of conservatively treated patients with asymptomatic high grade carotid stenosis. (2005) (31)
Low level laser therapy for treatment of primary and secondary Raynaud's phenomenon. (2004) (31)
Fibrinogen Predicts Restenosis after Endovascular Treatment of the Iliac Arteries (2002) (31)
Prognostic value of neutrophils in patients with asymptomatic carotid artery disease. (2013) (30)
Deep vein thrombosis and systemic inflammatory response: A pilot trial (2003) (30)
Cystatin C and the Risk for Cardiovascular Events in Patients With Asymptomatic Carotid Atherosclerosis (2010) (30)
High plasma heparin cofactor II activity protects from restenosis after femoropopliteal stenting (2004) (29)
Endovascular management of "endoleaks" after transluminal infrarenal abdominal aneurysm repair. (1998) (29)
Lipoprotein (a) in patients with spontaneous venous thromboembolism. (2007) (29)
Algorithms for the diagnosis of deep-vein thrombosis in patients with low clinical pretest probability. (2002) (29)
PGE1 analog alprostadil induces VEGF and eNOS expression in endothelial cells. (2005) (29)
Excessive Carotid In-Stent Neointimal Formation Predicts Late Cardiovascular Events (2004) (27)
Gender Differences in Outcome of Conservatively Treated Patients With Asymptomatic High Grade Carotid Stenosis (2005) (27)
Improvement of neurocognitive function after protected carotid artery stenting (2008) (27)
Mean platelet volume predicts outcome in patients with asymptomatic carotid artery disease (2014) (27)
Predicting renal failure after balloon angioplasty in high-risk patients. (2001) (27)
Polymorphism of the complement 5 gene and cardiovascular outcome in patients with atherosclerosis (2012) (27)
Quality of life after balloon angioplasty versus stent implantation in the superficial femoral artery: findings from a randomized controlled trial. (2007) (27)
Agreement of duplex ultrasonography vs. computed tomography angiography for evaluation of native and in-stent SFA re-stenosis--findings from a randomized controlled trial. (2012) (26)
Endovascular brachytherapy for prophylaxis of restenosis after femoropopliteal angioplasty: five-year follow-up--prospective randomized study. (2006) (26)
Is there improvement of "vascular depression" after carotid artery stent placement? (2006) (25)
Renal function and long-term mortality in patients with asymptomatic carotid atherosclerosis (2011) (25)
Endovascular stent implantation for treatment of peripheral artery disease (2007) (25)
Low level laser treatment of primary and secondary Raynaud's phenomenon. (2001) (25)
Reduction in renal function after renal arteriography and after renal artery angioplasty. (2002) (25)
Restenosis after Femoropopliteal PTA and Elective Stent Implantation: Predictive Value of Monocyte Counts (2003) (24)
Complement Component C5a Predicts Restenosis after Superficial Femoral Artery Balloon Angioplasty (2007) (24)
Vascular brachytherapy with 192Ir after femoropopliteal stent implantation in high-risk patients: twelve-month follow-up results from the Vienna-5 trial. (2005) (24)
Angioplasty and Elective Stenting of De Novo versus Recurrent Femoropopliteal Lesions: 1-Year Follow-up (2003) (24)
Outcome after Endovascular Treatment of Deep Femoral Artery Stenosis: Results in a Consecutive Patient Series and Systematic Review of the Literature (2006) (24)
Simvastatin Reduces Serum Level of Vascular Endothelial Growth Factor in Hypercholesterolemic Patients (2006) (24)
Duplex Ultrasound—Guided Femoropopliteal Angioplasty: Initial and 12-Month Results from a Case Controlled Study (2002) (24)
The 1-Year Clinical Impact of Rotational Aspiration Atherectomy of Infrainguinal Lesions (2011) (24)
Access site management after peripheral percutaneous transluminal procedures: Neptune pad compared with conventional manual compression. (2008) (23)
Endovascular brachytherapy: restenosis in de novo versus recurrent lesions of femoropopliteal artery--the Vienna experience. (2005) (23)
Non-randomized, prospective, multi-centre evaluation of the ABSOLUTE .035 peripheral self-expanding stent system for occluded or stenotic superficial femoral or proximal popliteal arteries (ASSESS Trial): acute and 30-day results. (2007) (23)
Femoropopliteal artery: initial and 6-month results of color duplex US-guided percutaneous transluminal angioplasty. (1996) (22)
Liposomal Heparin-Spraygel in Comparison with Subcutaneous Low Molecular Weight Heparin in Patients with Superficial Venous Thrombosis. A Randomized, Controlled, Open Multicentre Study (2003) (22)
The Effects of Endurance and Recreational Exercise on Subclinical Evidence of Atherosclerosis in Young Adults (2010) (22)
One-year outcome after percutaneous rotational and aspiration atherectomy in infrainguinal arteries in patient with and without type 2 diabetes mellitus. (2011) (22)
Idraparinux and liver enzymes: observations from the PERSIST trial (2003) (21)
Three-dimensional color Doppler sonography in carotid artery stenosis. (2003) (20)
Changes in determinants of blood rheology during treatment with haemodialysis and recombinant human erythropoietin. (1990) (20)
History of cardiovascular disease is associated with endothelial progenitor cells in peritoneal dialysis patients. (2005) (20)
Neurological Outcome of Conservative versus Endovascular Treatment of Patients with Asymptomatic High-Grade Carotid Artery Stenosis: A Propensity Score—Adjusted Analysis (2005) (19)
The role of soluble cell adhesion molecules in patients with suspected deep vein thrombosis (2003) (19)
TASC II section F on revascularization: commentary from an interventionist's point of view. (2007) (19)
D-dimer testing in the diagnosis of transfemoral pseudoaneurysm after percutaneous transluminal procedures. (2010) (19)
Platelet Deposition at Angioplasty Sites and Platelet Survival Time After PTA in lliac and Femoral Arteries: Investigations with Indium-111-Oxine Labelled Platelets in Patients with ASA (1.0 g/Day)-Therapy (1987) (19)
Platelet-monocyte cross talk and tissue factor expression in stable angina vs. unstable angina/non ST-elevation myocardial infarction (2011) (18)
Angioplasty and elective stenting of de novo versus recurrent femoropopliteal lesions: 1-year follow-up. (2003) (18)
Low doses of recombinant human tissue-type plasminogen activator for local thrombolysis in peripheral arteries. (1988) (18)
Haptoglobin phenotype 2-2 as a potentially new risk factor for spontaneous venous thromboembolism. (2005) (18)
TASC II Section E3 on the Treatment of Acute Limb Ischemia: Commentary from European Interventionists (2008) (18)
Inflammation and adverse cardiovascular outcome in patients with renal artery stenosis and peripheral artery disease. (2009) (18)
Influence of acetylsalicylic acid (1.0 g/day) on platelet survival time, beta-thromboglobulin and platelet factor 4 in patients with peripheral arterial occlusive disease. (1987) (18)
New stents for SFA. (2009) (18)
No effect of homocysteine‐lowering therapy on vascular inflammation and haemostasis in peripheral arterial occlusive disease (2006) (18)
Tissue concentration of clindamycin and gentamicin near ischaemic ulcers with transvenous injection in Bier's arterial arrest (1996) (17)
Thromboxane A2 and Prostacyclin Generation in the Microvasculature of Patients with Atherosclerosis – Effect of Low-Dose Aspirin (1989) (17)
Assessment of intima-media thickness of carotid arteries: evaluation of an automated computer software (2008) (17)
Pyridoxine therapy in patients with renal calcium oxalate calculi. (1983) (17)
The impact of dental disease on mortality in patients with asymptomatic carotid atherosclerosis. (2011) (17)
Interleukin-1 cluster combined genotype and restenosis after balloon angioplasty (2003) (17)
Quality of Life after Balloon Angioplasty versus Stent Implantation in the Superficial Femoral Artery: Findings from a Randomized Controlled Trial (2007) (17)
Interleukin-6 promoter genotype and restenosis after femoropopliteal balloon angioplasty: initial observations. (2004) (17)
Red cell distribution width and mortality in carotid atherosclerosis (2016) (16)
Thermoregulation and rheological properties of blood in primary Raynaud’s phenomenon and the vibration-induced white-finger syndrome (2005) (16)
Ultrasound with Levovist in the diagnosis of suspected calf vein thrombosis. (2001) (16)
C-reactive protein 3' UTR +1444C>T polymorphism in patients with spontaneous venous thromboembolism. (2006) (16)
CTA in the detection and quantification of vertebral artery pathologies: a correlation with color Doppler sonography (2007) (16)
Grading of Internal Carotid Artery Stenosis: Comparative Analysis of Different Flow Velocity Criteria and Multidetector Computed Tomographic Angiography (2006) (16)
Comments, opinions, and brief case reports: biosurgical debridement facilitates healing of chronic skin ulcers. (2002) (16)
Clinical outcome and prognostic factors for ischaemic ulcers treated with PTA in lower limbs. (2002) (16)
Influence of lipoprotein(a) on restenosis after femoropopliteal percutaneous transluminal angioplasty in Type 2 diabetic patients (2002) (15)
Interleukin-1 gene cluster variants and abdominal aortic aneurysms (2005) (15)
Grading of Internal Carotid Artery Stenosis: Can CTA Overcome the Confusion? (2006) (15)
A Validated Risk Score to Predict Outcomes after Carotid Stenting (2012) (15)
Endovascular brachytherapy prevents restenosis after femoropopliteal angioplasty: results of the Vienna-3 multicenter study (2003) (15)
Outcome of conservative therapy of patients with severe intermittent claudication. (2004) (15)
Spontaneous laser doppler flux distribution in ischemic ulcers and the effect of prostanoids: a crossover study comparing the acute action of prostaglandin E1 and iloprost vs saline. (1996) (15)
Prostanoids in the treatment of intermittent claudication--a meta-analysis. (2002) (15)
Thrombus precursor protein, endogenous thrombin potential, von‐Willebrand factor and activated factor VII in suspected deep vein thrombosis: is there a place for new parameters? (2003) (15)
[ESC guidelines for the treatment and diagnosis of peripheral artery disease. Guideline includes extracranial carotid artery, vertebral, mesenteric, renal, upper and lower extremity arteries]. (2012) (14)
Homocysteine levels in patients with Raynaud's phenomenon. (2002) (14)
Possible impact of iridium-192 source centering on restenosis rate after femoro-popliteal angioplasty and endovascular brachytherapy in Vienna-2 study. (2002) (14)
Vein bypass surgery for femoro-popliteal arteriosclerosis: influence of different risk factors on patient survival and the importance of anticoagulant treatment. (1988) (14)
Claudication: treatment options for femoropopliteal disease. (2011) (14)
Carotid ultrasound investigation as a prognostic tool for patients with diabetes mellitus (2019) (14)
Influence and interaction of diabetes and lipoprotein (a) serum levels on mortality of patients with peripheral artery disease (2007) (14)
Statin therapy has no significant effect on skin tissue cholesterol: results from a prospective randomized trial. (2005) (14)
The impact of selectins on mortality in stable carotid atherosclerosis (2015) (14)
Relation of small artery compliance and lipoprotein (a) in patients with atherosclerosis. (2002) (14)
A Review of Antithrombotic Therapy and the Rationale and Design of the Randomized Edoxaban in Patients With Peripheral Artery Disease (ePAD) Trial Adding Edoxaban or Clopidogrel to Aspirin After Femoropopliteal Endovascular Intervention (2015) (14)
Combined Effects of Inflammatory Status and Carotid Atherosclerosis: A 12-Year Follow-Up Study (2016) (14)
Traveller's thrombosis 2001. (2002) (14)
Acquired cystic disease of the kidneys in chronic hemodialyzed and renal transplant patients. (1984) (13)
[Therapy of acute ilio-femoral vein thrombosis]. (1987) (13)
Von Willebrand factor antigen levels predict major adverse cardiovascular events in patients with carotid stenosis of the ICARAS study. (2019) (13)
Prediction of recurrent venous thromboembolism by measuring ProC Global (2007) (13)
CTA Quantification of Internal Carotid Artery Stenosis: Application of Luminal Area vs. Luminal Diameter Measurements and Assessment of Inter‐observer Variability (2007) (12)
Matching carotid anatomy with carotid stents. (2008) (12)
p‐Hydroxyphenylacetaldehyde, the major product of tyrosine oxidation by the activated myeloperoxidase system can act as an antioxidant in LDL (2001) (12)
Effects of Transvenous Regional Guanethidine Block in the Treatment of Critical Finger Ischemia (2000) (12)
Insulin, C-peptide, and restenosis after femoral artery balloon angioplasty in type II diabetic and nondiabetic patients. (2005) (12)
The prognostic value of serum amyloid A for long‐term mortality among patients with subclinical carotid atherosclerosis (2019) (11)
[Prevention of pulmonary embolism]. (1992) (11)
Lack of influence of low-dose acetylsalicylic acid (100 mg daily) on platelet survival time, beta-thromboglobulin and platelet factor 4 in patients with peripheral arterial occlusive disease. (1988) (11)
Prevention of postvenographic thrombosis by heparin flush: fibrinogen uptake measurements. (1984) (11)
Laser Doppler anemometry distinguishes primary Raynaud phenomenon from VWF syndrome. (2004) (11)
Influence of systemic inflammation on efficiency of antiplatelet therapy in PAOD patients (2004) (11)
Thromboembolic complications in a patient with heparin-induced thrombocytopenia (HIT) showing cross-reactivity to a low molecular weight heparin-treatment with Org 10172 (Lomoparan). (1997) (10)
Renal artery PTA and stent implantation: immediate and late clinical and morphological outcome. (2002) (10)
Evidence of carotid atherosclerosis in orthopantomograms and the risk for future cardiovascular events. (2010) (10)
Excessive myocardial calcinosis in a chronic hemodialyzed patient (1987) (10)
Long-term follow-up after renal artery stenting (2003) (10)
Multidetector CT Angiography in the Followup of Patients Treated with Renal Artery Stents: Value of Different Reformation Techniques Compared with Axial Source Images (2007) (10)
Effect of statins on lipoprotein receptor expression in cell lines from human mast cells and basophils (2003) (9)
[Percutaneous transluminal angioplasty (PTA) in peripheral arterial occlusive disease of the lower extremities]. (1986) (9)
Beta endovascular brachytherapy using CO2-filled centering catheter for treatment of recurrent superficial femoropopliteal artery disease. (2009) (9)
Present Status of Endovascular Brachytherapy in Peripheral Arteries (2002) (9)
D-Dimer in Local Thrombolytic Therapy with Low Doses of Recombinant Human Tissue-Type Plasminogen Activator (rt-PA) in Patients with Peripheral Arterial Occlusive Disease (1990) (9)
Intravascular Brachytherapy from Theory to Practice (2001) (9)
Peripheral arterial occlusive disease. (2007) (9)
[Acute venous thrombosis: localization, extent and aetiology with special consideration of paraneoplasia]. (2008) (9)
Atorvastatin reduces thrombin generation after percutaneous coronary intervention independent of soluble tissue factor. (2005) (9)
Quality of life in patients with idiopathic subclavian vein thrombosis. (2010) (9)
Thrombin activatable fibrinolysis inhibitor (TAFI) and the risk of recurrent venous thromboembolism (2004) (9)
Innovative technologies for SFA occlusions: drug coated balloons in SFA lesions. (2012) (8)
The Prognostic Impact of Soluble Apoptosis-Stimulating Fragment on Mortality in Patients With Carotid Atherosclerosis (2011) (8)
Endovascular brachytherapy and late thrombotic occlusion. (2000) (8)
Endovascular brachytherapy in peripheral arteries. (2003) (8)
Endothelial Cell Seeding: Experience and First Clinical Results in Vienna (1987) (8)
The impact of uric acid on long-term mortality in patients with asymptomatic carotid atherosclerotic disease. (2015) (8)
Local low-dose streptokinase thrombolysis of a thrombosed arteriovenous fistula. (1984) (7)
Influence of systemic inflammation on the interpretation of response to antiplatelet therapy, monitored by PFA-100. (2005) (7)
[Primary biliary cirrhosis and scleroderma: long-term benign course of a complex autoimmune disease]. (1985) (7)
Vascular remodeling in atherosclerotic femoral arteries: three-dimensional US analysis. (2004) (7)
Impact of different therapeutic alternatives in treatment of severe limb ischemia: experiences on 190 consecutive patients at a department of medical angiology. (1999) (7)
Anti chlamydia antibodies in patients with thoracic and abdominal aortic aneurysms. (2002) (6)
[Austrian Guidelines for Prophylaxis of Venous Thromboembolism]. (2007) (6)
Carotid Stenting in a Case of Combined Kinking and Stenosis (2001) (6)
The cardiovascular risk marker asymmetrical dimethylarginine is not affected by venous thromboembolism. (2006) (6)
Treating Renal Artery Stenosis (2004) (6)
Accidental overdose of mitoxantrone in three patients (1989) (6)
VENOUS THROMBOSIS AND CYCLOSPORIN (1985) (6)
[Comparative pharmacokinetics of the beta-1 receptor blookader celiprolol after a single oral administration in subjects with health kidneys and in patients with impaired renal function]. (1985) (6)
Temporary vena cava filters do not always protect from fatal pulmonary embolism. (2000) (6)
Early postoperative changes after desobliteration of the carotid artery. Subsequent diagnostic control using a high resolution ultrasonic-real-time-duplex-scanner. (1986) (5)
[Transaminase increase: a largely unknown side-effect of heparin treatment (author's transl)]. (1980) (5)
Clinical long-term results of percutaneous transluminal angioplasty in patients with peripheral arterial occlusive disease. (2002) (5)
[Hematologic changes in patients under long-term hemodialysis and hemofiltration treatment with special reference to serum concentrations of folic acid and vitamin B 12]. (1984) (5)
Carotid Artery Stenting for the Prevention of Thromboembolic Stroke (2004) (5)
Advances in vascular brachytherapy over the last 10 years: focus on femoropopliteal applications. (2004) (5)
PGE 1 analog alprostadil induces VEGF and eNOS expression in endothelial cells (2005) (5)
Sunday, 26 August 2012 (2012) (5)
Consensus Document on Intermittent Claudication from the Central European Vascular Forum (C.E.V.F.)-3rd revision (2013) with the sharing of the Mediterranean League of Angiology and Vascular Surgery, and the North Africa and Middle East Chapter of International Union of Angiology. (2014) (5)
Parameters of the tissue factor pathway with coumadin/dipyridamole versus ticlopidine as adjunct antithrombotic-drug regimen in coronary artery stenting (2003) (5)
Multidetector CT Angiography with Perfusion Analysis in the Surveillance of Renal Artery Stents (2004) (5)
[Leriche syndrome: treatment with local lysis and subsequent percutaneous transluminal angioplasty]. (1996) (5)
Postoperative Platelet Diagnosis: A Prerequisite for Clinical Seeding (1987) (4)
1005-44 Vascular brachytherapy with 192iridium after femoropopliteal stenting in high-risk patients: Results from the vienna-5 trial (2004) (4)
Images in cardiovascular medicine. Multimodality imaging of hemangiectasia hypertrophicans (Klippel-Trenaunay-Parkes-Weber syndrome). (2004) (4)
Endovascular brachytherapy: effect on acute inflammatory response after percutaneous femoropopliteal arterial interventions. (2004) (4)
[Clinical, functional and morphological late results of venous thrombectomy]. (1983) (4)
To work in a hospital — A new risk factor for development of venous disease? (2003) (4)
Treatment parameters for beta and gamma devices in peripheral endovascular brachytherapy. (2004) (4)
Vasospasmus: a rare manifestation of homocystinuria. (2000) (4)
Plasminogen activator inhibitor-1 and outcome after femoropopliteal angioplasty: analysis of genotype and plasma levels (2003) (4)
[Mapping the capillary density of hands and feet in healthy probands]. (1987) (4)
Color duplex sonography guided stent placement in a stenosis of the superficial femoral artery. A case report. (1998) (3)
Herz Treating Renal Artery Stenosis A Statement Pro Endovascular Therapy (2004) (3)
The role of antithrombotic therapy on the patency of peripheral bypasses. (2000) (3)
Effects of intravenous prostaglandin E1 on arterial compliance: a randomized controlled trial. (2004) (3)
Impact of the Rapid-Exchange versus Over-the-Wire Technique on Procedural Complications of Renal Artery Angioplasty (2005) (3)
Colour duplex sonography-guided local lysis of occlusions in the femoro-popliteal region. (2000) (3)
3D-conformal radiotherapy for prevention of carotid recurrent in-stent restenosis: Initial experience (2005) (3)
Association of periprocedural neurological deficit in carotid stenting with increased anticardiolipin antibodies. (2009) (3)
Percutaneous instillation of physiological saline solution for the treatment of femoral pseudoaneuryms (2016) (3)
Usefulness of hemoglobin level to predict long-term mortality in patients with asymptomatic carotid narrowing by ultrasonography. (2012) (3)
Skin cholesterol: test performance, evaluation of potential determinants and correlation analysis with cardiovascular risk factors and circulating markers of inflammation. (2006) (3)
Hemostatic markers with bolus versus prolonged heparin after carotid artery stenting. (2003) (3)
PP35. Assessment of Self-Expanding Nitinol Stent Deformations Implanted into the Femoropopliteal Artery (2009) (3)
[Recurrence of spontaneous kidney rupture in a dialysis patient]. (1982) (3)
Skin tissue cholesterol is not related to vascular occlusive disease (2007) (3)
[Fibronectin and other immunologic parameters in chronic polyarthritis]. (1984) (3)
Coadministration of low-dose urokinase and abciximab in thrombolysis for lower limb ischemia. a safety study. (2001) (2)
[Sonographic problems in the assessment of abdominal aortic aneurysms]. (1983) (2)
[Thrombolysis using urokinase in acute phlebothrombosis]. (1984) (2)
Excessive ectasia of the femoral artery: an unknown late sequel of percutaneous transluminal angioplasty: case report. (1986) (2)
[Emergency endoscopy in patients with liver cirrhosis]. (1983) (2)
Stent-induced flow disturbances in the ipsilateral external carotid artery following internal carotid artery stenting: a temporary cause of jaw claudication (2017) (2)
[In vitro endothelialization of ePTFE vascular prostheses in clinical use: preliminary results]. (1990) (2)
Drug-eluting stents above the knee. (2011) (2)
[PTA stent implantation in the carotid artery: dangerous experiment or the treatment of the future?]. (1999) (2)
Local hirudin application — an aid in preventing occlusion of an arteriovenous fistula in dialysis patients? (1985) (2)
Plasma concentrations of ketanserin in chronic hemodialysed patients. (1986) (2)
A severe case of vascular thoracic outlet syndrome. (2000) (2)
Vasospasm of the scrotum--a manifestation of Raynaud's phenomenon? (2004) (2)
Resuscitation of Endovascular Brachytherapy Owing to Improved Logistics (2012) (2)
[Role of postoperative anticoagulant treatment following femoro-popliteal venous bypass. Interim evaluation of a controlled clinical study]. (1987) (2)
Outcome of conservative medical treatment of patients with infrarenal abdominal aortic aneurysms. (2002) (2)
THE IMPACT OF CELLULAR ADHESION MOLECULES ON MORTALITY IN PATIENTS WITH STABLE ATHEROSCLEROSIS (2015) (2)
[Prognosis of liver cirrhosis: results of a 14-year-long clinical follow-up study]. (1983) (2)
Polymorphism of the palladin gene and cardiovascular outcome in patients with atherosclerosis (2011) (2)
67 Intraarterial 192Ir HDR BT for prophylaxis of restenosis after femoropopliteal transluminal angioplasty; prospective; randomized trial-Vienna 2; results after 6 months minimum follow-up; risk factor analysis (1999) (2)
[Hemorheology and acute phase reaction following thrombendarterectomy of the extracranial carotid artery]. (1988) (2)
Hemorheology in systemic ultrahigh-dose thrombolytic therapy with streptokinase and urokinase. (1989) (1)
[Complete AV block in a heart catheter study using a Swan-Ganz catheter]. (1986) (1)
[Occlusive disease of the extracranial carotid artery: "spontaneous course" and early phase following thrombendarterectomy in image-producing ultrasound]. (1987) (1)
Integrative therapy in patients with intermittent claudication. (2015) (1)
[Atypical variant of a hepatocellular carcinoma with a favourable course (author's transl)]. (1982) (1)
[Randomized comparative study of the recurrence rate following femoro-popliteal PTA: high (1.0 g/die) vs low (0.1 g/die) acetylsalicylic acid dose]. (1991) (1)
[ESC guidelines for the treatment and diagnosis of peripheral artery disease. Guideline includes extracranial carotid artery, vertebral, mesenteric, renal, upper and lower extremity arteries]. (2012) (1)
[Peri-interventional drug therapy in PTA of supra-aortic blood vessels]. (2000) (1)
Abciximab reduces monocyte tissue factor after carotid angioplasty and stenting: role of monocyte platelet cross talk in cerebral microembolization (2003) (1)
[Mirizzi syndrome (author's transl)]. (1982) (1)
Progression und Regression in der Arteriosklerose (1987) (1)
[Prevention of cerebrovascular disorders]. (1991) (1)
Acute effect of cimetidine and pirenzepine on plasma parathyroid hormone and calcitonin in haemodialyzed patients (2004) (1)
The Evidence for Stenting in Femoropopliteal Occlusive Disease (2008) (1)
MONOCYTE-PLATELET AGGREGATES AND MICROPARTICLE FORMATION ARE REDUCED AFTER CAROTID STENTING (2008) (1)
Predicting Renal Failure after Balloon Angioplasty in High-Risk Patients (2001) (1)
Reproducibility of platelet survival time measurements in patients with peripheral arterial occlusive disease. (1987) (1)
CONSENSUS Superficial vein thrombosis : a consensus statement (2012) (1)
[Cystic renal changes in chronic hemodialysed patients]. (1983) (1)
Endovascular brachytherapy in peripheral arteries: Solution for restenosis or false hope? (2003) (1)
Complex Cases in Peripheral Vascular Interventions (2010) (1)
Ticlopidine induced prolonged leucopenia in a patient with immunocytoma and chronic hepatitis C. (1999) (1)
Influence of HMG-CoA-reductase inhibitors on the body fat status. (2006) (1)
Femoral stenting: what do the guidelines tell us. (2013) (1)
Lack of elevation of β-thromboglobulin and platelet factor 4 in plasma during exercise in patients with chronic peripheral arterial occlusive disease (1987) (0)
Chapter 4b. General complications of angiography and peripheral interventions - radiotoxicity (2007) (0)
Commentary: Carotid Artery Stenting: Last Chance to Escape the Already Prepared Moratorium? (2010) (0)
[Macroembolism as a complication of ultra-high dose urokinase lysis of occlusion of a bifurcation prosthesis]. (1993) (0)
Survival following an extremely high-dose of mitoxantrone in a 73-year-old female with small cell bronchial carcinoma (2004) (0)
1007-179 Exercise training increases the number of endothelial progenitor cells in patients with coronary heart disease and cardiovascular risk factors (2004) (0)
[Percutaneous transluminal angioplasty in peripheral arterial occlusive disease]. (1988) (0)
Identifying (high) risk patients for endovascular treatment – unfavorable medical comorbidities (2007) (0)
Long-term follow-up after percutaneous transluminal angioplasty of the distal abdominal aorta. (2004) (0)
Katheterbasierte γ-HDR-Brachytherapie der peripheren Gefäße (2002) (0)
Twenty-eight Year Old HIV Positive Male Patient with Ergotism. Interaction of Ergot-alkaloids and Protease-inhibitors (2005) (0)
Quiz of the Month, Answer / Publisher’s Note (1984) (0)
33 Endovascular HDR-brachythempy for prophylaxis of restenosis after femoropopliteal PTA; preliminary results from a randomised trial (1998) (0)
Autologous Stem Cell-Transplantation for Therapeu- tic Angiogenesis in Patients with Chronic Critical Lower Limb Ischemia (2004) (0)
Pharmacological Prerequisites for Treatment of Complex Patients with Peripheral Artery Disease (2010) (0)
Thrombin-activatable ﬁbrinolysis inhibitor and the risk for recurrent venous thromboembolism (2004) (0)
[Value and limitations of cross sectional echocardiography in the diagnosis of infective endocarditis (author's transl)]. (1982) (0)
[Instrumental diagnosis of peripheral arterial occlusive disease]. (1988) (0)
Regular Article Heme oxygenase-1 gene promoter polymorphism is associated with abdominal aortic aneurysm (2002) (0)
Sensitivity of125J-fibrinogen uptake test for diagnosis of established venous thrombosis in heparinized patients (1986) (0)
Local paclitaxel delivery in peripheral vascular disease. (2008) (0)
[The radiologic diagnosis of venous diseases. A challenge]. (1993) (0)
Complicatons in Peripheral Vascular Interventions (2007) (0)
Why Should We Tackle Complex Lesions by Endovascular Techniques (2010) (0)
[Percutaneous transluminal angioplasty of subclavian stenoses]. (1988) (0)
[Percutaneous transluminal angioplasty of subclavian stenoses]. (1988) (0)
[Does anticoagulant treatment modify patient survival following femoropopliteocrural venous bypass operations?]. (1987) (0)
Regarding "Stenting for femoropopliteal lesions". (2008) (0)
Chamber Winds and Brass Concert (2011) (0)
Femoral Artery: CFA, SFA, Profunda Femoris Artery Lesions (2013) (0)
Elevated plasma fibronectin levels in nephrotic syndrome (1984) (0)
[Proximal lesions of the subclavian artery and common carotid artery on the left side--experiences with direct anastomosis (transposition)]. (1988) (0)
[Effect of acute viral hepatitis B on erythropoiesis in chronic hemodialyzed patients]. (1983) (0)
P1634The impact of diabetes on long term mortality (12 years) among patients with carotid atherosclerotic disease (2018) (0)
Is serum alpha 1-antitrypsin deficiency a contraindication for kidney transplantation? (1985) (0)
[Clinical significance of bacterial contamination of enteral nutrition solutions]. (1983) (0)
Lack of elevation of beta-thromboglobulin and platelet factor 4 in plasma during exercise in patients with chronic peripheral arterial occlusive disease. (1987) (0)
Prostanoids for intermittent claudication. (2004) (0)
Recent advances in peripheral in-stent restenosis. (2010) (0)
AAA- a further step towards a moratorium for aspirin in the primary prevention. (2010) (0)
Platelet disposition at angioplasty sites and platelet survival time after PTA in iliac and femoral arteries. (1989) (0)
Specific complications by vessel area or specific scenarios (2007) (0)
Endovascular therapy for peripheral vascular disease (2013) (0)
A matched case control study (2017) (0)
Increased platelet aggregation (PA) but no further hemorheological alterations in patients with recent transient ischemic attacks (TIAs) (2018) (0)
Lower Extremity Artery Disease (2021) (0)
Being prepared – standards for patient care and adequate bail-out equipment (2007) (0)
Complications – General Considerations (2007) (0)
Introduction to complications in peripheral vascular interventions – frequency of complications and worst scenarios (2007) (0)
Long-term results of systemic thrombolysis therapy in aorto-iliac occlusive disease. (2001) (0)
54 Possible impact of 192-IR endovascular brachytherapy source centering on the restenosis rate in vienna-2 study (2000) (0)
Peripheral Vascular Disease: Basic and Clinical Perspectives (2013) (0)
Arterial and venous access site complications (2007) (0)
Should I prefer chest pain over leg pain? (2012) (0)
Beta endovascular brachytherapy using CO2-filled centering catheter for in-stent restenosis of superficial femoral artery (2008) (0)
62 Vienna experience: Peripheral vascular (2000) (0)
Advances in Vascular Brachytherapy over the Last 10 Years: Focus on Femoropopliteal Applications (2004) (0)
Comprar Complications in Peripheral Vascular Interventions | Erich Minar | 9781841846286 | Informa Healthcare (2007) (0)
Abstract 15195: MMP-9 Serum Levels Predict Carotid Artery Plaque Progression in Patients without but Not in Patients with Statin Treatment (2011) (0)
Meet the Expert - Carotis Intervention: From Puncture to Closure (2004) (0)
Latest developments in SFA management. (2014) (0)
877-2 Endovascular gamma radiation therapy inhibits recurrence in restenotic lesions of the femoropopliteal artery: The Vienna experience (2004) (0)
Endovascular irradiation after femoropopliteal angioplasty. (2004) (0)
[A 7-years clinical course of a 41-year-old female patient with Takayasu disease]. (1983) (0)
[Fat in the parenteral feeding of malnourished patients]. (1983) (0)
Abstract 1963: Elevated Anticardiolipin Antibodies are an Independent Risk Factor for Neurological Complications in Carotid Stenting (2006) (0)
The prostaglandin E-1 analog Alprostadil induces VEGF and eNOS expression in endothelial cells (2005) (0)
[Lack of effect of low dose acetylsalicylic acid (100 mg/die) on thrombocyte survival and beta-thromboglobulin (beta-TG) and platelet factor 4 (PF 4) in patients with peripheral arterial occlusive disease]. (1989) (0)
[Prostatic adenomectomy in dialysis patients]. (1983) (0)
[Emergency endoscopy in patients with chronic alcohol abuse]. (1982) (0)
Adenomectomy in a patient on regular dialysis treatment. (1984) (0)
Spiral-CT-Venography of the Lower Extremity in Deep Venous Thrombosis: First Results (1995) (0)
5760The impact of serum amolyoid A on long term mortality (12 years) in patients with carotid atherosclerosis (2017) (0)
[Percutaneous quantitative shunt flow measurement and flow measurement of large transport arteries in chronic dialysis patients]. (1984) (0)
[Hemorheologic findings in patients with heart valve replacement]. (1990) (0)
61. Treatment of peripheral arterial occlusive disease with a combination of pentoxifylline and very low dose ASS is well tolerated and effectively lowers fibrinogen levels (1996) (0)
[Media sclerosis of dialysis and kidney transplant patients]. (1983) (0)
TASC II Section F on Revascularization: Commentary from an Interventionist's Point of View (2007) (0)
88 Intraarterial hdr brachytherapy after femoro-popliteal PTA + stent implantation. Pilot study vienna-4 (2000) (0)
Endovascular-first strategy for all patients with peripheral arterial disease? (2012) (0)
[Assessment of thrombocyte deposits and thrombocyte survival following catheter dilatation of the lower extremities using 111-indium marked thrombocytes]. (1988) (0)
[Local streptokinase thrombolysis in a Cimino shunt thrombosis]. (2008) (0)
[Rare cause of ureteral obstruction following renal transplantation]. (1983) (0)
Endovascular irradiation after femoropopliteal angioplasty. Authors' reply (2004) (0)
Effect of combination therapy with cimetidine and pirenzepine on plasma parathyroid hormone and calcitonin levels in hemodialyzed patients (1984) (0)
Factor V leiden mutation is associated with increased risk for periprocedural neurological deficits in carotid stenting (2003) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Erich Minar?

Erich Minar is affiliated with the following schools: